726 50 WATSON
Pill imprint 726 50 WATSON has been identified as Meperidine hydrochloride 50 mg.
Meperidine is used in the treatment of pain; light sedation and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.
Meperidine 50 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Meperidine hydrochloride Images
- Imprint:
-
726 50
WATSON - Strength:
- 50 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- confectioners sugar
lactose monohydrate
magnesium stearate
povidone
sodium starch glycolate
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0726
Advertisement
More Meperidine Hydrochloride resources
- Meperidine (Wolters Kluwer)
- Meperidine Syrup (Wolters Kluwer)
- Meperidine Tablets (Wolters Kluwer)
- meperidine (Cerner Multum)
- meperidine (Micromedex) - Includes Dosage Information
- meperidine Injection (Micromedex) - Includes Dosage Information
- Meperidine Hydrochloride (AHFS DI)
- Meperidine (FDA)
- Meperidine Injection (FDA)
- Meperidine Tablets (FDA)
- Meperidine Hydrochloride (Wolters Kluwer)
Search Again
